Lam Research Corporation $LRCX Holdings Lowered by Mosley Wealth Management

Mosley Wealth Management reduced its stake in Lam Research Corporation (NASDAQ:LRCX) by 67.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,002 shares of the semiconductor company’s stock after selling 2,062 shares during the period. Mosley Wealth Management’s holdings in Lam Research were worth $434,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Fideuram Asset Management Ireland dac bought a new stake in shares of Lam Research in the 4th quarter worth $10,035,000. Generali Investments Management Co LLC boosted its stake in Lam Research by 62.0% during the fourth quarter. Generali Investments Management Co LLC now owns 36,274 shares of the semiconductor company’s stock valued at $6,209,000 after buying an additional 13,878 shares in the last quarter. Rokos Capital Management LLP boosted its stake in Lam Research by 42.0% during the first quarter. Rokos Capital Management LLP now owns 259,921 shares of the semiconductor company’s stock valued at $55,532,000 after buying an additional 76,840 shares in the last quarter. Aware Super Pty Ltd as trustee of Aware Super acquired a new position in Lam Research during the first quarter worth about $59,973,000. Finally, Krilogy Financial LLC grew its holdings in Lam Research by 19.5% during the first quarter. Krilogy Financial LLC now owns 28,111 shares of the semiconductor company’s stock worth $6,006,000 after acquiring an additional 4,584 shares during the period. 84.61% of the stock is currently owned by institutional investors.

Insider Activity

In related news, Director Abhijit Y. Talwalkar sold 18,282 shares of the company’s stock in a transaction that occurred on Monday, July 13th. The shares were sold at an average price of $335.00, for a total value of $6,124,470.00. Following the completion of the sale, the director owned 87,142 shares in the company, valued at approximately $29,192,570. This represents a 17.34% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Neil J. Fernandes sold 7,659 shares of the firm’s stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $309.60, for a total transaction of $2,371,226.40. Following the completion of the transaction, the senior vice president directly owned 58,470 shares of the company’s stock, valued at $18,102,312. This represents a 11.58% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 80,441 shares of company stock worth $27,614,296 over the last 90 days. 0.31% of the stock is owned by company insiders.

Lam Research Trading Up 1.1%

Shares of LRCX opened at $314.00 on Friday. The business’s 50-day moving average price is $337.47 and its 200 day moving average price is $286.09. The company has a current ratio of 2.63, a quick ratio of 1.91 and a debt-to-equity ratio of 0.30. The stock has a market capitalization of $392.91 billion, a P/E ratio of 54.51, a P/E/G ratio of 1.23 and a beta of 1.84. Lam Research Corporation has a 1-year low of $94.11 and a 1-year high of $438.50.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings data on Wednesday, July 29th. The semiconductor company reported $1.82 EPS for the quarter, beating analysts’ consensus estimates of $1.69 by $0.13. Lam Research had a net margin of 31.27% and a return on equity of 67.60%. The company had revenue of $6.72 billion during the quarter, compared to analyst estimates of $6.66 billion. During the same period in the prior year, the firm earned $1.33 earnings per share. The business’s quarterly revenue was up 30.0% on a year-over-year basis. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. Analysts expect that Lam Research Corporation will post 9.32 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the stock. HSBC reissued a “hold” rating and issued a $333.00 price target on shares of Lam Research in a report on Monday, July 27th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $320.00 price objective on shares of Lam Research in a research note on Thursday, July 30th. Raymond James Financial set a $425.00 target price on shares of Lam Research in a report on Wednesday, June 10th. Zacks Research raised shares of Lam Research from a “hold” rating to a “strong-buy” rating in a research note on Friday, July 17th. Finally, Wall Street Zen cut shares of Lam Research from a “buy” rating to a “hold” rating in a report on Sunday, May 10th. One investment analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $358.47.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.